Drug-resistant infections team

We work with experts and partner organisations, including research, policy and industry experts, clinical scientists, product developers, NGOs and funders, to explore global solutions to drug-resistant infections.

Contact us

To contact the team, email drugresistantinfections@wellcome.ac.uk.

Team contacts

Tim Jinks

Head of Drug-resistant Infections Programme

Jeremy Knox

Policy and Advocacy Lead

Rebecca Sugden

Policy Adviser

Sian Williams

Policy Officer

Oliver Williams

Policy Officer

Gemma Buckland-Merrett

Science Innovation Lead

Francesca Chiara

Science Officer

Janet Midega

Science Officer

Joanna Wiecek

Science Officer

Chibuzor Uchea

Science Officer

Charlotte Chapman

Programme Manager

Janvi Patel

PA/Team Coordinator

Veronika Jacobi

Team Administrator

Our work

Drug-resistant infections: transforming the global response

We want to transform the world's approach towards stemming the rise of infections caused by bacteria resistant to antibiotics.

News

Schoolchildren in India show the comics they produced.

Explainer | 10 December 2019

How to write persuasively about drug-resistant infections

A researcher and two nurses look at patient data.

Opinion | 13 November 2019

With better global data we can outsmart drug-resistant infections by Gemma Buckland Merrett

A community health volunteer with mother and her baby in the Satungal village in western Kathmandu.

Opinion | 5 November 2019

It’s time to rethink the way we talk about one of the most urgent threats to our health by Jeremy Farrar

More news

Reports

Report 29 October 2019 Updated 4 December 2019

Reframing Resistance

DownloadPDF 1.1MB

This report aims to guide experts, communicators and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

Report 14 October 2019 Updated 11 December 2019

Reframing Resistance

[Summary] This report aims to help experts and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.